HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY

(HZNP)
  Rapport
Temps Différé Nasdaq  -  22:00 12/08/2022
67.47 USD   +0.55%
04/08HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY : Morgan Stanley reste à l'achat
ZM
04/08HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY : BMO Capital toujours positif
ZM
04/08HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY : UBS de acheteur à neutre sur le titre
ZM
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
03/08SECTOR UPDATE : Health Care Stocks Hanging on for Modest Gains
03/08SECTOR UPDATE : Health Care Stocks Edging Higher This Afternoon
03/08SECTOR UPDATE : Health Care Stocks Advance Pre-Bell Wednesday
03/08SECTOR UPDATE : Health Care
03/08TRANSCRIPT : Horizon Therapeutics Public Limited Company, Q2 2022 Earnings Call, Aug 03, 2..
03/08Horizon Therapeutics Reports Lower Q2 Adjusted Earnings as Sales Rise; Lowers Full-Year..
03/08HORIZON THERAPEUTICS PUBLIC LTD CO MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL C..
03/08HORIZON THERAPEUTICS PUBLIC : plc Reports Second-Quarter 2022 Financial Results and Revise..
03/08HORIZON THERAPEUTICS : Q2 Earnings Snapshot
03/08Earnings Flash (HZNP) HORIZON THERAPEUTICS Reports Q2 Revenue $876.4M
03/08Earnings Flash (HZNP) HORIZON THERAPEUTICS Reports Q2 EPS $1.07
03/08Horizon Therapeutics Public Limited Company Reports Impairment of Goodwill for the Seco..
03/08Horizon Therapeutics plc Reports Second-Quarter 2022 Financial Results and Revises Full..
03/08Horizon Therapeutics Public Limited Company Reports Earnings Results for the Second Qua..
03/08Horizon Therapeutics Public Limited Company Provides Earnings Guidance for the Full-Yea..
29/07INSIDER SELL : Horizon Therapeutics
25/07Horizon Therapeutics plc Named a Best Company for Multicultural Women
21/07Horizon Therapeutics plc Announces Inaugural #RAREis Global Advocate Grant Recipients
12/07Horizon Therapeutics plc Announces Wanda Durant Has Joined Olympian Gail Devers to Rais..
11/07Horizon Therapeutics plc - FDA Approves KRYSTEXXA Injection Co-Administered With Methot..
11/07Horizon Therapeutics plc Announces Wanda Durant Has Joined Olympian Gail Devers to Rais..
08/07Horizon Therapeutics Says US FDA Approves sBLA for Krystexxa Injection With Methotrexat..
08/07FDA Approves KRYSTEXXA® (pegloticase) Injection Co-Administered With Methotrexate, Expa..
08/07FDA Approves KRYSTEXXA® (pegloticase) Injection Co-Administered With Methotrexate, Expa..
07/07Horizon Therapeutics plc to Release Second-Quarter 2022 Financial Results and Host Webc..
27/06Horizon Therapeutics plc - New Analysis Finds UPLIZNA (inebilizumab) Effective Among Eu..
24/06New Analysis Finds UPLIZNA® (inebilizumab) Effective Among European Populations with Ne..
24/06Horizon Therapeutics Public Limited Company Announces New Analysis Finds UPLIZNA (inebi..
16/06Horizon Therapeutics plc Named One of the Fortune Best Workplaces in Chicago
16/06Horizon Therapeutics plc Submits Regulatory Filing for UPLIZNA (inebilizumab) in Brazil
15/06Horizon Therapeutics Files for Brazilian Approval of Autoimmune Disease Treatment
15/06Horizon Therapeutics plc Submits Regulatory Filing for UPLIZNA® (inebilizumab) in Brazi..
15/06Horizon Therapeutics plc Submits Regulatory Filing for Uplizna® (Inebilizumab) in Brazi..
15/06Horizon Therapeutics plc Named One of the Fortune Best Workplaces in Chicago™
14/06TRANSCRIPT : Horizon Therapeutics Public Limited Company Presents at Goldman Sachs 43rd An..
13/06Horizon Therapeutics plc - Analysis of Pooled Data from TEPEZZA (teprotumumab-trbw) Cli..
11/06Analysis of Pooled Data from TEPEZZA® (teprotumumab-trbw) Clinical Trials Reinforces Sa..
11/06Horizon Therapeutics Public Limited Company Announces Results of A New Analysis Examini..
09/06Horizon Therapeutics plc Named a Top Company for Executive Women
06/06Horizon Therapeutics plc to Present at the Goldman Sachs 43rd Annual Global Health Care..
06/06INSIDER SELL : Horizon Therapeutics
03/06INSIDER SELL : Horizon Therapeutics
02/06Horizon Therapeutics plc - Data Presented from the MIRROR Randomized Controlled Trial D..
02/06Horizon Therapeutics plc to Highlight Data and Education on Thyroid Eye Disease (TED) a..
01/06Horizon Therapeutics plc - Analysis from the Phase 3 N-MOmentum Study Demonstrates the ..
01/06Data Presented from the MIRROR Randomized Controlled Trial Demonstrate KRYSTEXXA® (pegl..
31/05Horizon Therapeutics plc Wins 2022 International CSR Excellence Award for #RAREis Adopt..
31/05Analysis from the Phase 3 N-MOmentum Study Demonstrates the Effectiveness of UPLIZNA® (..
31/05Horizon Therapeutics plc Announces Analysis from the Phase 3 N-Momentum Study Demonstra..
24/05Horizon Therapeutics plc to Present MIRROR Randomized Controlled Trial Primary Endpoint..
17/05Horizon Therapeutics Says First Patient Enrolled in Phase 2 Study of Proposed Treatment..
17/05Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating D..
17/05Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating D..
16/05Horizon Therapeutics plc Ranked Second in Overall Corporate Reputation in U.S. PatientV..
13/05INSIDER SELL : Horizon Therapeutics
11/05Horizon Therapeutics plc Announces Dara Mann as a Healthcare Businesswomen's Associatio..
11/05Horizon Therapeutics plc Launches Letter-Writing Campaign to Empower Those Living with ..
09/05Horizon Therapeutics and Chicago Sky Announce Multi-Year Partnership
04/05Horizon Therapeutics Posts Higher Q1 Non-GAAP Earnings, Net Sales
04/05TRANSCRIPT : Horizon Therapeutics Public Limited Company, Q1 2022 Earnings Call, May 04, 2..
04/05HORIZON THERAPEUTICS PUBLIC LTD CO MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL C..
04/05HORIZON THERAPEUTICS : Q1 Earnings Snapshot
04/05HORIZON THERAPEUTICS PUBLIC LTD CO : Results of Operations and Financial Condition, Change..
04/05Earnings Flash (HZNP) HORIZON THERAPEUTICS Posts Q1 Revenue $885.2M, vs. Street Est of ..
04/05Earnings Flash (HZNP) HORIZON THERAPEUTICS Posts Q1 EPS $1.34, vs. Street Est of $1.14
04/05Horizon Therapeutics Public Limited Company Reports Earnings Results for the First Quar..
04/05Horizon Therapeutics Public Limited Company Announces Executive Changes
04/05Horizon Therapeutics plc Reports First-Quarter 2022 Financial Results
04/05Horizon Therapeutics Public Limited Company Provides Earnings Guidance for the Full Yea..
03/05Horizon Therapeutics Says Phase 2 Trial of Dazodalibep for Rheumatoid Arthritis Met Pri..
03/05Topline Data for Dazodalibep (HZN-4920) Meets Primary Endpoint in Rheumatoid Arthritis
03/05Horizon Therapeutics plc Announces Topline Data for Dazodalibep (HZN-4920) Meets Primar..
02/05Horizon Therapeutics plc Launches #RAREis Global Advocate Grant Program to Support the ..
02/05HORIZON THERAPEUTICS PUBLIC : AMENDED AND RESTATED 2020 EQUITY INCENTIVE PLAN - Form 8-K
02/05HORIZON THERAPEUTICS PUBLIC LTD CO : Change in Directors or Principal Officers, Submission..
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY